In vivo administration of interferon γ does not cause marrow aplasia in mice with a targeted disruption of FANCC

This publication has 15 references indexed in Scilit:

• The Fanconi anemia complementation group C gene product: structural evidence of multifunctionality
  Blood, 2001
• Functional correction of FA-C cells withFANCC suppresses the expression of interferon γ–inducible genes
  Blood, 2001
• Role of double-stranded RNA-dependent protein kinase in mediating hypersensitivity of Fanconi anemia complementation group C cells to interferon γ, tumor necrosis factor-α, and double-stranded RNA
  Blood, 2001
• Preclinical Protocol for in Vivo Selection of Hematopoietic Stem Cells Corrected by Gene Therapy in Fanconi Anemia Group C
  Molecular Therapy, 2001
• Tumor necrosis factor-? and CD95 ligation suppress erythropoiesis in fanconi anemia C gene knockout mice
  Journal of Cellular Physiology, 1999
• The Fanconi anemia group C gene product modulates apoptotic responses to tumor necrosis factor-α and Fas ligand but does not suppress expression of receptors of the tumor necrosis factor receptor superfamily
  Experimental Hematology, 1999
• Heparin Decreases the Blood Clearance of Interferon-γ and Increases Its Activity by Limiting the Processing of Its Carboxyl-terminal Sequence
  Journal of Biological Chemistry, 1996
• Correction of Fanconi Anemia Type C Phenotypic Abnormalities Using a Clinically Suitable Retroviral Vector Infection Protocol
  Cell Transplantation, 1996
• Increased expression of Fas antigen on bone marrow CD34⁺ cells of patients with aplastic anaemia
  British Journal of Haematology, 1995
• A functionally active retrovirus vector for gene therapy in Fanconi anemia group C
  Blood, 1994